DrugPatentWatch Database Preview
Clobetasol propionate - Generic Drug Details
What are the generic sources for clobetasol propionate and what is the scope of patent protection?
Clobetasol propionate
is the generic ingredient in eleven branded drugs marketed by Glenmark Pharms Ltd, Ingenus Pharms Llc, Perrigo Israel, Perrigo Uk Finco, Taro, Mylan, Acp Nimble, Aleor Dermaceuticals, Amneal Pharms Llc, Fougera Pharms Inc, Glenmark Pharms, Lupin Ltd, Rising, Teligent Pharma Inc, Teva Pharms Usa, Torrent, Xiromed, Zydus Pharms, Fougera Pharms, Novast Labs, Hi Tech Pharma, Encore Dermat, Perrigo Co, Actavis Mid Atlantic, Cadila, Hi Tech, Galderma Labs Lp, Encube, Novel Labs Inc, Galderma Labs, Macleods Pharms Ltd, Saptalis Pharms, Tolmar, Wockhardt Bio Ag, Akorn, Apotex, and Paddock Llc, and is included in eighty-six NDAs. There are seven patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.Clobetasol propionate has seventy-five patent family members in twenty-six countries.
There are fourteen drug master file entries for clobetasol propionate. Fifty-three suppliers are listed for this compound.
Summary for clobetasol propionate
| International Patents: | 75 |
| US Patents: | 7 |
| Tradenames: | 11 |
| Applicants: | 37 |
| NDAs: | 86 |
| Drug Master File Entries: | 14 |
| Suppliers / Packagers: | 53 |
| Bulk Api Vendors: | 63 |
| Clinical Trials: | 51 |
| Patent Applications: | 6,503 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for clobetasol propionate |
| Drug Sales Revenues: | Drug sales revenues for clobetasol propionate |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for clobetasol propionate |
| DailyMed Link: | clobetasol propionate at DailyMed |
Recent Clinical Trials for clobetasol propionate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Malmö University | Phase 2/Phase 3 |
| Skane University Hospital | Phase 2/Phase 3 |
| Salvat | Phase 3 |
Pharmacology for clobetasol propionate
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for clobetasol propionate
Paragraph IV (Patent) Challenges for CLOBETASOL PROPIONATE
| Tradename | Dosage | Ingredient | NDA | Submissiondate |
|---|---|---|---|---|
| IMPOYZ | CREAM;TOPICAL | clobetasol propionate | 209483 | 2019-12-06 |
| OLUX E | AEROSOL, FOAM;TOPICAL | clobetasol propionate | 022013 | 2010-02-25 |
| CLOBEX | SPRAY;TOPICAL | clobetasol propionate | 021835 | 2008-09-29 |
| CLOBEX | SHAMPOO;TOPICAL | clobetasol propionate | 021644 | 2008-01-09 |
| CLOBEX | LOTION;TOPICAL | clobetasol propionate | 021535 | 2006-03-27 |
| OLUX | AEROSOL, FOAM;TOPICAL | clobetasol propionate | 021142 | 2005-06-27 |
US Patents and Regulatory Information for clobetasol propionate
Expired US Patents for clobetasol propionate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Fougera Pharms | TEMOVATE | clobetasol propionate | CREAM;TOPICAL | 019322-001 | Dec 27, 1985 | Start Trial | Start Trial |
| Mylan | OLUX | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 021142-001 | May 26, 2000 | Start Trial | Start Trial |
| Galderma Labs Lp | CLOBEX | clobetasol propionate | LOTION;TOPICAL | 021535-001 | Jul 24, 2003 | Start Trial | Start Trial |
| Galderma Labs Lp | CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835-001 | Oct 27, 2005 | Start Trial | Start Trial |
| Mylan | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | Start Trial | Start Trial |
| Galderma Labs | CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644-001 | Feb 5, 2004 | Start Trial | Start Trial |
| Fougera Pharms | TEMOVATE | clobetasol propionate | OINTMENT;TOPICAL | 019323-001 | Dec 27, 1985 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for clobetasol propionate
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2016228574 | Start Trial |
| South Africa | 200006073 | Start Trial |
| European Patent Office | 3141246 | Start Trial |
| Israel | 139940 | Start Trial |
| Brazil | PI0514806 | Start Trial |
| South Korea | 20170123335 | Start Trial |
| Hong Kong | 1089956 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
NCE-1 Patent Challenge Dates 2020 - 2021
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
